Endophthalmitis after intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections is a severe, vision-threatening complication with a reported incidence ranging from 0.02 to 0.05% [1–5]. This evidence concerns the gene VEGFA and endophthalmitis.